Procavea Biotech
PrivateLast Round
Seed
Jun 1, 2024
Total Funding Raised
$343,000
Company Overview
Procavea Biotech operates in Healthcare & Life Sciences and is based in Zurich. Its latest recorded funding round was a Seed round in June 2024.
Procavea Biotech is a biotechnology company that develops a proprietary protein-based drug delivery platform for RNA therapeutics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Procavea Biotech Comparables
Compare Procavea Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Vivatides Therapeutics | 81% | |
| Mana.bio | 79% | |
| Aanastra Inc. | 78% |
For institutional investors. Book with your work email.
Procavea Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jun 1, 2024 | ||||
| Accelerator | Dec 27, 2023 | ||||
| Grant | Oct 31, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Procavea Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Gebert Rüf Stiftung | Grant |
| Kickfund | Seed |
| Venture Kick | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 1, 2024
Seed round raised with Kickfund as an investor.
- Oct 31, 2023
$165K grant received from Gebert Rüf Stiftung.
For institutional investors. Book with your work email.
Procavea Biotech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Procavea Biotech's valuation, stock price, and market status.
Is Procavea Biotech a public or private company?
Procavea Biotech is a private company.
What is the current stock price of Procavea Biotech?
Procavea Biotech is a private company, so its shares have no public market price. Caplight tracks Procavea Biotech's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Procavea Biotech worth (valuation)?
Valuation information for Procavea Biotech is not publicly available.
Can I buy Procavea Biotech stock?
Procavea Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Procavea Biotech's last funding round?
Procavea Biotech's most recent funding round was Seed on June 1, 2024.
Who are the main investors in Procavea Biotech?
Key investors in Procavea Biotech include Gebert Rüf Stiftung, Kickfund, Venture Kick.
Will Procavea Biotech IPO soon?
No public IPO plans have been announced for Procavea Biotech.
How can I track Procavea Biotech secondary market activity?
Caplight tracks bids, offers, and trades in Procavea Biotech's shares on secondary markets.